Sentence examples for processes for the evaluation from inspiring English sources

The contributions that this book makes to development of better and more comprehensive processes for the evaluation of early detection devices, and to establishing rules for the approval of early detection technologies by governmental agencies are certainly worthy of consideration by scientists who are interested in breast cancer research.

We use a Poisson arrival process for the evaluation of the delay behavior for both schemes.

A generalized and automated process for the evaluation of system uncertainty using computer simulation is presented.

The Chylla–Haase polymerization reactor is widely accepted as a benchmark process for the evaluation of control strategies for batch reactors.

Eventually, two options were accessible to proceed with our study: first, to obtain an order or approval from the commander of the hospital of mandatory participation in the research; second, as described by some researchers, to implement the MSF process for the evaluation, we should first achieve the readiness of the organization and its employee.

The peer review process for the evaluation of manuscripts for publication needs to be better understood by the orthopaedic community.

These conditions highlight the importance of developing a fair process for the evaluation of future innovations in surgery.

For a summary of the advantages of having a DRI-like process for the evaluation of bioactives, see Table  1.> Dietary fiber is an example of a bioactive with a DRI value.

One issue with setting up a DRI-like process for the evaluation of bioactives is the very wide range of the strength of the science behind the intake of a bioactive and a purported reduced risk of disease.

In most of Canada, there is a separate HTA assessment process for the evaluation of cancer versus noncancer drugs; in Québec, the process is the same, but there is a separate advisory committee that focuses on cancer drugs; and in the United Kingdom, there is a separate set of criteria and cost-effectiveness threshold for end-of-life (cancer) drugs.

Although not implemented in this study, based on this experience, we recommend that future prospective retrospective studies (1) be amended to specify the predictive biomarker hypothesis as a primary objective in the clinical study protocol when the specific predictive biomarker is identified and (2) ensure a process for the evaluation of viable tumor samples at the time of enrollment.